Article Details

Pfizer and Biohaven's VYDURA® (Rimegepant) Granted First Ever Marketing Authorization ...

Retrieved on: 2022-04-28 13:51:15

Tags for this article:

Click the tags to see associated articles and topics

Pfizer and Biohaven's VYDURA® (Rimegepant) Granted First Ever Marketing Authorization .... View article details on hiswai:

Excerpt

Pfizer and Biohaven's VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up